Kingdon Capital Management, L.L.C. Iovance Biotherapeutics, Inc. Transaction History
Kingdon Capital Management, L.L.C.
- $834 Million
- Q3 2024
A detailed history of Kingdon Capital Management, L.L.C. transactions in Iovance Biotherapeutics, Inc. stock. As of the latest transaction made, Kingdon Capital Management, L.L.C. holds 300,000 shares of IOVA stock, worth $1.73 Million. This represents 1.51% of its overall portfolio holdings.
Number of Shares
300,000Holding current value
$1.73 Million% of portfolio
1.51%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding IOVA
# of Institutions
316Shares Held
239MCall Options Held
3.77MPut Options Held
1.7M-
Vanguard Group Inc Valley Forge, PA27.3MShares$157 Million0.0% of portfolio
-
Perceptive Advisors LLC New York, NY26.6MShares$153 Million6.53% of portfolio
-
Mhr Fund Management LLC New York, NY24MShares$138 Million28.52% of portfolio
-
Black Rock Inc. New York, NY21.2MShares$122 Million0.0% of portfolio
-
State Street Corp Boston, MA13.2MShares$76 Million0.01% of portfolio
About IOVANCE BIOTHERAPEUTICS, INC.
- Ticker IOVA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 157,800,992
- Market Cap $909M
- Description
- Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...